Drawing for MDSP

USPTO serial 78072447

MDSP

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
MCCRAY, RENEE
Law office
INTENT TO USE UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MDSP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer programs relating to assays for the diagnosis of diseases, namely computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substances; scientific instruments for developing assays for the diagnosis of diseases, and for developing chemical markers for disease states, and for performing diagnostics for diseases, and for determining targets for drugs, and for determining protein and peptide sequences, namely mass spectrometers, sample separation apparatus, sample enrichment apparatus, sample preparation apparatus, optical detectors, and micro-fluidic sample processing apparatusACTIVE
042Medical research, namely developing assays for the diagnosis of diseases; developing chemical markers which indicate the presence of disease states; performing diagnostics for diseases, namely analyzing and reporting on patient specimens; determining biological targets for drugs, namely determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughtput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry processes and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services and developing methods to reduce the sample sizes needed, and to increase the reliability of assays; and leasing of medical equipment, namely mass spectrometers, electrophoresis analyzers, separation apparatus, namely liquid chromatographs and capillary electrophoresis apparatus, optical detection systems, namely ultraviolet, fluorescence and chemiluminescent detectors, microfluid apparatus and sample preparation apparatusACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 28, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 26, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 19, 2004EX3GSOU EXTENSION 3 GRANTED
Apr 15, 2004CFITCASE FILE IN TICRS
Apr 1, 2004MAILPAPER RECEIVED
Mar 30, 2004EXT3SOU EXTENSION 3 FILED
Oct 17, 2003EX2GSOU EXTENSION 2 GRANTED
Sep 30, 2003EXT2SOU EXTENSION 2 FILED
Sep 30, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 7, 2003EX1GSOU EXTENSION 1 GRANTED
Mar 31, 2003EXT1SOU EXTENSION 1 FILED
Mar 31, 2003MAILPAPER RECEIVED
Oct 1, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 9, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2002NPUBNOTICE OF PUBLICATION
Mar 26, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance